Compounds > 2-methacryloyloxyethyl phosphorylcholine
Page last updated: 2024-09-03

2-methacryloyloxyethyl phosphorylcholine and paclitaxel

2-methacryloyloxyethyl phosphorylcholine has been researched along with paclitaxel in 1 studies

Compound Research Comparison

Studies
(2-methacryloyloxyethyl phosphorylcholine)		Trials
(2-methacryloyloxyethyl phosphorylcholine)		Recent Studies (post-2010)
(2-methacryloyloxyethyl phosphorylcholine)		Studies
(paclitaxel)		Trials
(paclitaxel)		Recent Studies (post-2010) (paclitaxel)
240314531,8745,72915,395

Protein Interaction Comparison

ProteinTaxonomy2-methacryloyloxyethyl phosphorylcholine (IC50)paclitaxel (IC50)
Integrin beta-3Homo sapiens (human)0.034
Integrin alpha-V Homo sapiens (human)0.034
ATP-dependent translocase ABCB1Homo sapiens (human)2.598
Botulinum neurotoxin type A Clostridium botulinum5.2
UDP-glucuronosyltransferase 2B7Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1-6Homo sapiens (human)4.9
Substance-K receptorHomo sapiens (human)6.125
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)4.9
UDP-glucuronosyltransferase 1A4Homo sapiens (human)4.9
UDP-glucuronosyltransferase 2B10 Homo sapiens (human)4.9
Delta-type opioid receptorHomo sapiens (human)4.202
Tyrosine-protein kinase MerHomo sapiens (human)4.9
Tubulin beta-3 chainHomo sapiens (human)0.0082
Beta-tubulin Leishmania donovani1
Nucleotide-binding oligomerization domain-containing protein 2Homo sapiens (human)7.9433
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.26
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.28

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, N; Ishihara, K; Jinno, H; Kitagawa, Y; Shimada, T; Ueda, M; Wada, M; Watanabe, J1

Other Studies

1 other study(ies) available for 2-methacryloyloxyethyl phosphorylcholine and paclitaxel

ArticleYear
Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
    Anticancer research, 2009, Volume: 29, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Delivery Systems; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Infusions, Subcutaneous; Methacrylates; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Paclitaxel; Phosphorylcholine; Tissue Distribution; Tumor Cells, Cultured

2009